Institutional Ownership Nuvectis Pharma, Inc. (NVCT)
This table provides information about the institutional ownership of Nuvectis Pharma, Inc. (NVCT). We have compiled data on the 32 institutions that hold shares in the stock, with a total of 1.65 Million shares, which have been reported (via 13F filing form) to have a value of $8.26 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nbc Securities, Inc.
Birmingham, AL |
Oct 15, 2024 Q3 2024 |
300
shares
|
$1,505
0.0% of portfolio
|
Q2 2024
Added 200.0%
|
|
|
Hollencrest Capital Management
|
Oct 31, 2024 Q3 2024 |
280
shares
|
$1,405
0.0% of portfolio
|
Q3 2023
Reduced 90.79%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
192
shares
|
$963
0.0% of portfolio
|
Q3 2024
Reduced 98.7%
|
|
|
Steward Partners Investment Advisory, LLC
|
Nov 14, 2024 Q3 2024 |
100
shares
|
$501
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Nisa Investment Advisors, LLC
|
Oct 24, 2024 Q3 2024 |
12
shares
|
$60
0.0% of portfolio
|
Q3 2024
Reduced 94.34%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
11
shares
|
$55
0.0% of portfolio
|
Q3 2024
Reduced 15.38%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|